MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202617061946 A) filed by Mirati Therapeutics, Inc. on May 15, 2026, for Crystalline Forms Of Fumarate Salt Of Mrtx0902.
Inventors include Wang, Nan; Shah, Harsh; Kuang, Shanming; O'Connor, James; Chadha, Aastha; Scattolin, Thomas; and Chen, Cheng.
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: The present invention relates to fumarate crystalline forms of MRTX0902 ((R)-2-methyl-3-(1-((4-methyl-7-morpholinopyrido[3,4-d]pyridazin-1- yl)amino)ethyl)benzonitrile), pharmaceutical compositions comprising the crystalline forms, processes for preparing the crystalline forms and methods of use thereof.
Disclaimer: Curated by HT Syndication.
